Myeloma Patients Europe
65
  • Welcome to Myeloma Patients Europe - Hans Scheurer

    613 views 2 years ago
    Myeloma Patients Europe is a network of highly efficient, effective and sustainable myeloma patient organisations across Europe.

    Our mission is to provide education, information and support to member groups and to advocate at European, national and local levels for the best possible research and equal access to the best possible treatment and care.

    Find out more in our website http:// www.mpeurope.org Show less
    Read more
  • MPE Webinars Play all

    This item has been hidden
  • MPE Educational Clips Play all

    • EHA 2019 myeloma highlights - Duration: 9 minutes, 40 seconds.

      • 1 week ago
      • 106 views
      Interview filmed with Dr Laurent Garderet, Department of Hematology at Pitié Salpêtrière Hospital in Paris, France, to summarise the most important updates presented in the European Hematology Asso...
    • AL Amyloidosis - Duration: 7 minutes, 25 seconds.

      • 2 months ago
      • 47 views
      Summary of the Plenary session on AL Amyloidosis given by Dr Moshe Gatt, Hadassah Hebrew University Medical Center, Jerusalem (Israel) and Daniel Drimer, president of Amyloidosis Israel during the ...
    • Myeloma Treatment Updates - Duration: 7 minutes, 26 seconds.

      • 2 months ago
      • 117 views
      Summary of the talk given by Prof. Heinz Ludwig, Wilhelminen Cancer Research Institute, Austria, about myeloma treatment updates during the MPE Annual General Meeting (AGM) held in Munich, Germany ...
    • Surrogate end-points in myeloma and AL amyloidosis - Duration: 4 minutes, 34 seconds.

      • 2 months ago
      • 38 views
      Summary of the talk given by Dr Moshe Gatt, Hadassah Hebrew University Medical Center, Jerusalem (Israel), on surrogate end-points and biomarkers in myeloma and AL amyloidosis during the MPE Annual...
    • Measuring and utilising quality of life - Duration: 4 minutes, 18 seconds.

      • 2 months ago
      • 49 views
      Summary of the talk given by Dr Jayne Galinsky, Health Services Research Manager at Myeloma UK, on Measuring and utilising quality of life during the MPE Annual General Meeting (AGM) held in Munich...
    • The role of CAR-T - Duration: 4 minutes, 59 seconds.

      • 2 months ago
      • 52 views
      Summary of the talk given by Dr. Michael Hudecek, University of Wuerzburg, Germany, about the role of CAR-T cells in myeloma and AL amyloidosis at the MPE Annual General Meeting 2019 held in Munich...
    • Clinical challenges in myeloma Sonja Zweegman - Duration: 7 minutes, 12 seconds.

      • 10 months ago
      • 100 views
      Dr Sonja Zweegman, professor of hematology, Head of department of hematology in the VU University Medical Center, in Amsterdam (the Netherlands) explains in this video the clinical challenges in my...
    • Jan Geissler - Patient involvement in clinical research - Duration: 5 minutes, 15 seconds.

      • 2 years ago
      • 71 views
      Jan Geissler, co-founder of CML Advocates Network and former director of the European Patients Academy on Therapeutic Innovation, explains the meaning of patient involvement in research and the cha...
    • ECCO 2017 Highlights - Duration: 4 minutes, 27 seconds.

      • 2 years ago
      • 490 views
      Summary of the European Cancer Organisation (ECCO) Congress held in Amsterdam on 27-30 January 2017.

      Follow us on:

      · Facebook - https://www.facebook.com/pages/Myeloma-Patients-Europe/14......
    • EHA 2017 Myeloma Highlights - Dr Anna Sureda - Duration: 3 minutes, 33 seconds.

      • 2 years ago
      • 232 views
      Dr Anna Sureda, Head of Hematology Department, Institut Català d'Oncología (ICO), Spain, explains the most important highlights presented during the European Hematology Association (EHA) Annual Mee...
    • What is AL amyloidosis? - Duration: 6 minutes, 25 seconds.

      • 2 years ago
      • 384 views
      AL amyloidosis is a serious condition the amyloid forming protein is derived from the light chain component of a protein in the blood called monoclonal immunoglobulin.
    • What is a clinical trial? - Duration: 10 minutes.

      • 3 years ago
      • 83 views
      Clinical trials are research studies that test how well new medical approaches work in people. Their importance is increasingly growing in the field of myeloma as researchers are trying to develop ...
    This item has been hidden
  • European Atlas of Access to Myeloma Treatment Play all

    The current therapeutic approach of multiple myeloma has made significant strides towards in the last decade. New treatments and diagnosis criteria have obtained greater survival rates as well as a better quality of life for patients.

    However, there are still significant differences in access to treatment and care which are a potential source of inequity and could mean some patients may live longer and with a better quality of life than others depending on the country the live in.

    In this setting, Myeloma Patients Europe in close liaison with Avedis Donabedian Research Foundation has been working intensively during the last two years on the development of the European Atlas of Access to Myeloma Treatment to identify the variation of access to treatment in the European countries as well as its possible causes. All of this aiming to collaborate in the efforts to improve access to myeloma treatment in Europe.
    This item has been hidden
to add this to Watch Later

Add to

Loading playlists...